EVERSANA announced expanded capabilities for its AI-powered commercialization platform, adding medical affairs and commercial functions. The update includes medical information support, MLR automation, and analytics aimed at streamlining content development and knowledge reuse across commercialization workflows. EVERSANA said the platform now extends beyond marketing-operations pilots toward scaling AI across the enterprise while maintaining governance and compliance controls required in the pharma industry. The announcement highlights a practical shift from isolated AI experiments to integrated deployment—potentially accelerating how teams manage congress-ready materials, medical information workflows, and sales enablement content governance.